Pharmaceutical Consulting Based on Expert Industry Knowledge
When a drug is packaged and sits on a shelf, chemical transformations can take place over time that change the molecular structure of the drug. Prior to FDA approval, you are expected to limit chemical degradation reactions from oxidation, hydrolysis, and nitrosation of secondary amine impurities. Our experts provide the insight you need to limit these chemical transformations in your formulation.
Many drugs have very low water solubility. Many such drugs can thus have very slow dissolution rates which limit human exposure levels. We provide expertise on how to measure and thus optimize drug dissolution rates from your conventional or solid dispersion based formulations.
